Search published articles


Showing 2 results for Mohseni Salehi Monfared

Ak. Khoshkhoonejad , Sh. Mohseni Salehi Monfared , Hr. Hassanjani Roshan ,
Volume 17, Issue 1 (7 2004)
Abstract

Statement of Problem: Chronic periodontitis is one of the most prevalent periodontal diseases in the world which may be treated through surgical or non-surgical approaches.
Purpose: The aim of this study was to compare the efficacy of Doxycycline and placebo following SRP in non-surgical treatment of chronic periodontitis.
Materials and Methods: This double blind interventional study was conducted on patients attended to the periodontology department of Tehran faculty of dentistry from 2002 to 2003. After SRP, 22 cases and 23 controls were received Doxycycline and placebo, 20 mg twice a day for 3 months, respectively. Bleeding on probing (BOP), pocket depth (PD)<6mm and PD>7mm, and also clinical attachment level (CAL)<6mm and CAL>7mm in cases and controls after 3 and 6 months were compared by student t-test.Results: BOP after 3 and 6 months in Doxycycline recipients following SRP were significantly lower than in placebo recipients (P^0.007 and P=0.045 respectively). PD<6mm, PD>7mm, CAL<6mm and CAL>7mm in 3 and 6 months after SRP in cases were much lower than controls.
Conclusion: This study showed that the administration of Doxycycline for 3 months after SRP resulted in improvement of clinical indices as compared with SRP alone. Therefore, Doxycycline administration is recommended for chronic periodontitis treatment after SRP.
Y. Soleimani Shayesteh , Sh. Mohseni Salehi Monfared , S. Eskandarion ,
Volume 19, Issue 3 (4 2006)
Abstract

Background and Aim: Intrabony periodontal defects are important problems in periodontology and up to now several ways have been suggested for their treatment .Treatment with enamel matrix derivatives (EMD) has been shown to enhance periodontal regeneration. There is limited information available from clinical trials regarding the performance of EMD in the treatment of periodontal intrabony defects. This study was designed to compare the clinical and radiographic effects of EMD treatment to that of open flap debridment (OFD) for two and three walled intrabony defects.

Materials and Methods: 18 patients were included in this clinical trial which have 24 two and/ or three intrabony defects. Defects were randomly divided into two groups (test and control). Defects in test group were treated with flap surgery plus EMD and in control group with open flap debridment. At baseline and at 3 and 6 months follow up, clinical and radiographic measurements were performed. Data were analyzed using Greenhouse-Geisser test with p<0.05 as the limit of significance.

Results: At 3 and 6 months, mean probing pocket depth reduction was greater in the test group (EMD) (4.33 mm and 4.70 mm) compared to the OFD group (2.54 mm and 3.09 mm). Mean values for clinical attachment gain in the EMD group after 3 and 6 months were 4.29 mm and 4.98 mm, and in OFD group were 2.83 and 2.82 mm respectively. Radiographic bone gain measured by radiovisiography technique was greater in the EMD group compared to the OFD group (4.66 mm in EMD and 1.11 mm in OFD group after 3 months and 5.78 mm in EMD and 1.39 mm in OFD group after 6 months).

Conclusion: Based on the results of this study, treatment with flap surgery and EMD compared to open flap debridment, produced more favorable clinical improvements in two and three walled intrabony defects.



Page 1 from 1     

© 2024 , Tehran University of Medical Sciences, CC BY-NC 4.0

Designed & Developed by: Yektaweb